Related references
Note: Only part of the references are listed.2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Erroneous Augmentation of Multiplex Assay Measurements in Patients With Rheumatoid Arthritis Due to Heterophilic Binding by Serum Rheumatoid Factor
Derrick J. Todd et al.
ARTHRITIS AND RHEUMATISM (2011)
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study
Christine K. Iannaccone et al.
RHEUMATOLOGY (2011)
Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic?
Diederik P. C. de Rooy et al.
RHEUMATOLOGY (2011)
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis
Nataliya Milman et al.
CLINICAL BIOCHEMISTRY (2010)
Evaluation of Selected Rheumatoid Arthritis Activity Scores for Office-based Assessment
Mary Beth Sullivan et al.
JOURNAL OF RHEUMATOLOGY (2010)
Standardization of Joint Examination Technique Leads to a Significant Decrease in Variability Among Different Examiners
Mathias Grunke et al.
JOURNAL OF RHEUMATOLOGY (2010)
Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis
Daitaro Kurosaka et al.
JOURNAL OF RHEUMATOLOGY (2010)
RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): Agreement With DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) Activity Categories, Scored in Five Versus More Than Ninety Seconds
Theodore Pincus et al.
ARTHRITIS CARE & RESEARCH (2010)
A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation
Benjamin Rhodes et al.
PLOS MEDICINE (2010)
Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis
T. Uhlig et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%-45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United States
Tuulikki Sokka et al.
JOURNAL OF RHEUMATOLOGY (2009)
Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis
Y. Valle et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories
Theodore Pincus et al.
JOURNAL OF RHEUMATOLOGY (2008)
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative Routine Assessment of Patient Index Data (RAPID) scores on a Multidimensional Health Assessment Questionnaire (MDHAQ)
Theodore Pincus et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2007)
Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis
Sang-Won Lee et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Comparison of Disease Activity Score (DAS) 28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values
Eisuke Inoue et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
B. Combe et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial
YPM Goekoop-Ruiterman et al.
ARTHRITIS AND RHEUMATISM (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
C Grigor et al.
LANCET (2004)
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
JS Smolen et al.
RHEUMATOLOGY (2003)
Matrix metalloproteinases-3,-8,-9 as markers of disease activity and joint damage progression in early rheumatoid arthritis
I Tchetverikov et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
JM Bathon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
